Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia

British Journal of Haematology

Volumn 168, Issue 3, 2015, Pages 405-412

  Barker, Juliet N ^a   Fei, Mingwei ^b   Karanes, Chatchada ^c   Horwitz, Mitchell ^d   Devine, Steven ^e   Kindwall Keller, Tamila L ^f   Holter, Jennifer ^g   Adams, Alexia ^b   Logan, Brent ^b   Navarro, Willis H ^h   Riches, Marcie ⁱ  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g University of Oklahoma Medical Center   (United States)

^h NATIONAL MARROW DONOR PROGRAM   (United States)

ⁱ H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Acute leukaemia; Adult cord blood transplantation; Double cord; Relapse; Transplant related mortality

Indexed keywords

ACUTE LEUKEMIA; ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; ENGRAFTMENT; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LEUKEMIA RELAPSE; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NEUTROPHIL ENGRAFTMENT; OVERALL SURVIVAL; PROSPECTIVE STUDY; ACUTE DISEASE; ADOLESCENT; FETUS BLOOD; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; LEUKEMIA; LYMPHOCYTE COUNT; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHIL; PATHOLOGY; PHASE 2 CLINICAL TRIAL; PROCEDURES; RECURRENT DISEASE; THROMBOCYTE; TRANSPLANTATION; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; BLOOD PLATELETS; FETAL BLOOD; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA; LYMPHOCYTE COUNT; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; PROSPECTIVE STUDIES; RECURRENCE; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84921434405     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13136     Document Type: Article

References (35)

1. Alousi, A., Bolanos-Meade, J. & Lee, S.J. (2013) Graft-versus-host disease: state of the Science. Biology of Blood and Marrow Transplantation, 19, S102-S108.
2. Anasetti, C., Logan, B.R., Lee, S.J., Waller, E.K., Weisdorf, D.J., Wingard, J.R., Cutler, C.S., Westervelt, P., Woolfrey, A., Couban, S., Ehninger, G., Johnston, L., Maziarz, R.T., Pulsipher, M.A., Porter, D.L., Mineishi, S., McCarty, J.M., Khan, S.P., Anderlini, P., Bensinger, W.I., Leitman, S.F., Rowley, S.D., Bredeson, C., Carter, S.L., Horowitz, M.M. & Confer, D.L. (2012) Peripheral-blood stem cells versus bone marrow from unrelated donors. New England Journal of Medicine, 367, 1487-1496.
3. Avery, S., Shi, W., Lubin, M., Gonzales, A.M., Heller, G., Castro-Malaspina, H., Giralt, S., Kernan, N.A., Scaradavou, A. & Barker, J.N. (2011) Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood, 117, 3277-3285.
4. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., Miller, J.S. & Wagner, J.E. (2003) Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood, 102, 1915-1919.
5. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B., Miller, J.S., Verfaillie, C.M. & Wagner, J.E. (2005) Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 105, 1343-1347.
6. Barker, J.N., Abboud, M., Rice, R.D., Hawke, R., Schaible, A., Heller, G., La Russa, V. & Scaradavou, A. (2009) A "no-wash" albumin-dextran dilution strategy for cord blood unit thaw: high rate of engraftment and a low incidence of serious infusion reactions. Biology of Blood and Marrow Transplantation, 15, 1596-1602.
7. Barker, J.N., Byam, C.E., Kernan, N.A., Lee, S.S., Hawke, R.M., Doshi, K.A., Wells, D.S., Heller, G., Papadopoulos, E.B., Scaradavou, A., Young, J.W. & van den Brink, M.A. (2010a) Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biology of Blood and Marrow Transplantation, 16, 1541-1548.
8. Barker, J.N., Scaradavou, A. & Stevens, C.E. (2010b) Combined effect of total nucleated cell dose and HLA-match on transplant outcome in 1061 cord blood recipients with hematological malignancies. Blood, 115, 1843-1849.
9. Bashey, A., Zhang, X., Sizemore, C.A., Manion, K., Brown, S., Holland, H.K., Morris, L.E. & Solomon, S.R. (2013) T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. Journal of Clinical Oncology, 31, 1310-1316.
10. Bautista, G., Cabrera, J.R., Regidor, C., Fores, R., Garcia-Marco, J.A., Ojeda, E., Sanjuan, I., Ruiz, E., Krsnik, I., Navarro, B., Gil, S., Magro, E., de Laiglesia, A., Gonzalo-Daganzo, R., Martin-Donaire, T., Rico, M., Millan, I. & Fernandez, M.N. (2009) Cord blood transplants supported by co-infusion of mobilized hematopoietic stem cells from a third-party donor. Bone Marrow Transplantation, 43, 365-373.
11. Brunstein, C., Barker, J.N., Weisdorf, D.J., DeFor, T.E., Miller, J.S., Blazar, B.R., McGlave, P.B. & Wagner, J.E. (2007) Umbilical cord blood transplantation after non-myeloablative conditioning: impact on transplant outcomes in 110 adults with hematological disease. Blood, 110, 3064-3070.
12. Brunstein, C.G., Gutman, J.A., Weisdorf, D.J., Woolfrey, A.E., Defor, T.E., Gooley, T.A., Verneris, M.R., Appelbaum, F.R., Wagner, J.E. & Delaney, C. (2010) Allogeneic hematopoietic cell transplantation for hematological malignancy: relative risks and benefits of double umbilical cord blood. Blood, 116, 4693-4699.
13. Brunstein, C.G., Fuchs, E.J., Carter, S.L., Karanes, C., Costa, L.J., Wu, J., Devine, S.M., Wingard, J.R., Aljitawi, O.S., Cutler, C.S., Jagasia, M.H., Ballen, K.K., Eapen, M. & O'Donnell, P.V. (2011) Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood, 118, 282-288.
14. Copelan, E., Casper, J.T., Carter, S.L., van Burik, J.A., Hurd, D., Mendizabal, A.M., Wagner, J.E., Yanovich, S. & Kernan, N.A. (2007) A scheme for defining cause of death and its application in the T cell depletion trial. Biology of Blood and Marrow Transplantation, 13, 1469-1476.
15. Cutler, C., Multani, P., Robbins, D., Kim, H.T., Le, T., Hoggatt, J., Pelus, L.M., Desponts, C., Chen, Y.B., Rezner, B., Armand, P., Koreth, J., Glotzbecker, B., Ho, V.T., Alyea, E., Isom, M., Kao, G., Armant, M., Silberstein, L., Hu, P., Soiffer, R.J., Scadden, D.T., Ritz, J., Goessling, W., North, T.E., Mendlein, J., Ballen, K., Zon, L.I., Antin, J.H. & Shoemaker, D.D. (2013) Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood, 122, 3074-3081.
16. Delaney, C., Brashem-Stein, C., Voorhies, H., Gutman, J., Dallas, M., Heimfeld, S. & Bernstein, I. (2008) Notch-mediated expansion of human cord blood progenitor cells results in rapid myeloid reconstitution in vivo following myeloablative cord blood transplantation. Blood, 112, 212.
17. Delaney, C., Gutman, J.A. & Appelbaum, F.R. (2009) Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications. British Journal of Haematology, 147, 207-216.
18. Eapen, M., Rubinstein, P., Zhang, M.J., Stevens, C., Kurtzberg, J., Scaradavou, A., Loberiza, F.R., Champlin, R.E., Klein, J.P., Horowitz, M.M. & Wagner, J.E. (2007) Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369, 1947-1954.
19. Eapen, M., Rocha, V., Sanz, G., Scaradavou, A., Zhang, M.J., Arcese, W., Sirvent, A., Champlin, R.E., Chao, N., Gee, A.P., Isola, L., Laughlin, M.J., Marks, D.I., Nabhan, S., Ruggeri, A., Soiffer, R., Horowitz, M.M., Gluckman, E. & Wagner, J.E. (2010) Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. The Lancet Oncology, 11, 653-660.
20. Eapen, M., Klein, J.P., Sanz, G.F., Spellman, S., Ruggeri, A., Anasetti, C., Brown, M., Champlin, R.E., Garcia-Lopez, J., Hattersely, G., Koegler, G., Laughlin, M.J., Michel, G., Nabhan, S.K., Smith, F.O., Horowitz, M.M., Gluckman, E. & Rocha, V. (2011) Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. The Lancet Oncology, 12, 1214-1221.
21. Eapen, M., Klein, J.P., Ruggeri, A., Spellman, S., Lee, S.J., Anasetti, C., Arcese, W., Barker, J.N., Baxter-Lowe, L.A., Brown, M., Fernandez-Vina, M.A., Freeman, J., He, W., Iori, A.P., Horowitz, M.M., Locatelli, F., Marino, S., Maiers, M., Michel, G., Sanz, G.F., Gluckman, E. & Rocha, V. (2014) Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood, 123, 133-140.
22. Filipovich, A.H., Weisdorf, D., Pavletic, S., Socie, G., Wingard, J.R., Lee, S.J., Martin, P., Chien, J., Przepiorka, D., Couriel, D., Cowen, E.W., Dinndorf, P., Farrell, A., Hartzman, R., Henslee-Downey, J., Jacobsohn, D., McDonald, G., Mittleman, B., Rizzo, J.D., Robinson, M., Schubert, M., Schultz, K., Shulman, H., Turner, M., Vogelsang, G. & Flowers, M.E. (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation, 11, 945-956.
23. Gluckman, E. & Rocha, V. (2006) Donor selection for unrelated cord blood transplants. Current Opinion in Immunology, 18, 565-570.
24. Laughlin, M.J., Eapen, M., Rubinstein, P., Wagner, J.E., Zhang, M.J., Champlin, R.E., Stevens, C., Barker, J.N., Gale, R.P., Lazarus, H.M., Marks, D.I., van Rood, J.J., Scaradavou, A. & Horowitz, M.M. (2004) Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. New England Journal of Medicine, 351, 2265-2275.
25. de Lima, M., McNiece, I., Robinson, S.N., Munsell, M., Eapen, M., Horowitz, M., Alousi, A., Saliba, R., McMannis, J.D., Kaur, I., Kebriaei, P., Parmar, S., Popat, U., Hosing, C., Champlin, R., Bollard, C., Molldrem, J.J., Jones, R.B., Nieto, Y., Andersson, B.S., Shah, N., Oran, B., Cooper, L.J., Worth, L., Qazilbash, M.H., Korbling, M., Rondon, G., Ciurea, S., Bosque, D., Maewal, I., Simmons, P.J. & Shpall, E.J. (2012) Cord-blood engraftment with ex vivo mesenchymal-cell coculture. New England Journal of Medicine, 367, 2305-2315.
26. Liu, H., Rich, E.S., Godley, L., Odenike, O., Joseph, L., Marino, S., Kline, J., Nguyen, V., Cunningham, J., Larson, R.A., Del Cerro, P., Schroeder, L., Pape, L., Stock, W., Wickrema, A., Artz, A.S. & van Besien, K. (2011) Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood, 118, 6438-6445.
27. Ponce, D.M., Sauter, C., Devlin, S., Lubin, M., Gonzales, A.M., Kernan, N.A., Scaradavou, A., Giralt, S., Goldberg, J.D., Koehne, G., Perales, M.A., Young, J.W., Castro-Malaspina, H., Jakubowski, A., Papadopoulos, E.B. & Barker, J.N. (2013a) A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. Biology of Blood and Marrow Transplantation, 19, 799-803.
28. Ponce, D.M., Gonzales, A., Lubin, M., Castro-Malaspina, H., Giralt, S., Goldberg, J.D., Hanash, A.M., Jakubowski, A., Jenq, R., Papadopoulos, E.B., Perales, M.A., van den Brink, M.R., Young, J.W., Boulad, F., O'Reilly, R.J., Prockop, S., Small, T.N., Scaradavou, A., Kernan, N.A., Stevens, C.E. & Barker, J.N. (2013b) Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biology of Blood and Marrow Transplantation, 19, 904-911.
29. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H.G., Beatty, P., Hows, J. & Thomas, E.D. (1995) 1994 consensus conference on acute GVHD grading. Bone Marrow Transplantation, 15, 825-828.
30. Purtill, D., Smith, K.A., Devlin, S., Meagher, R., Tonon, J., Lubin, M., Ponce, D.M., Giralt, S., Kernan, N.A., Scaradavou, A., Stevens, C.E. & Barker, J.N. (2014) Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is inluenced by cord blood bank practice. Blood, pii: blood-2014-03-566216 [Epub ahead of print].
31. Rodrigues, C.A., Sanz, G., Brunstein, C.G., Sanz, J., Wagner, J.E., Renaud, M., de Lima, M., Cairo, M.S., Furst, S., Rio, B., Dalley, C., Carreras, E., Harousseau, J.L., Mohty, M., Taveira, D., Dreger, P., Sureda, A., Gluckman, E. & Rocha, V. (2009) Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. Journal of Clinical Oncology, 27, 256-263.
32. Shpall, E.J., Bollard, C.M. & Brunstein, C. (2011) Novel cord blood transplant therapies. Biology of Blood and Marrow Transplantation, 17, S39-S45.
33. Sorror, M.L., Maris, M.B., Storb, R., Baron, F., Sandmaier, B.M., Maloney, D.G. & Storer, B. (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood, 106, 2912-2919.
34. Verneris, M.R., Brunstein, C.G., Barker, J., MacMillan, M.L., DeFor, T., McKenna, D.H., Burke, M.J., Blazar, B.R., Miller, J.S., McGlave, P.B., Weisdorf, D.J. & Wagner, J.E. (2009) Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood, 114, 4293-4299.
35. Wagner, J.E., Barker, J.N., DeFor, T.E., Baker, K.S., Blazar, B.R., Eide, C., Goldman, A., Kersey, J., Krivit, W., MacMillan, M.L., Orchard, P.J., Peters, C., Weisdorf, D.J., Ramsay, N.K. & Davies, S.M. (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood, 100, 1611-1618.